--- title: "Adia Med (ADIA) stock listing, news and investor profile" url: "https://aibio.space/companies/adia-med/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Adia Med, Inc. (OTC: ADIA), United States. Listing facts, related biotech companies and news on aibio.space." --- ADIA Adia Med, Inc. OTC · United States # Adia Med (ADIA) news Mergers · 2026-10-06 ## [Adia Med agrees to sell 30% of Adia Labs to QCM Biologics for $1,500,000](https://aibio.space/news/adia-med-agrees-sell-30-percent-adia-labs-qcm-biologics-1-500-000/) The buyer, run by David Konn, pays $1,000,000 in cash and signs a $500,000 note at 7% interest, secured by a pledge of the units. ## Latest Adia Med news We have not published a story on Adia Med yet. When there is news, it will appear here. ## Adia Med at a glance - **Ticker**: ADIA - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $128,115 ### Related companies - [LFTD PARTNERS INC.](https://aibio.space/companies/lftd-partners/) OTC: LIFD - [NEUROONE MEDICAL TECHNOLOGIES](https://aibio.space/companies/neuroone-medical-technologies/) NASDAQ: NMTC - [Penumbra](https://aibio.space/companies/penumbra/) NYSE: PEN - [VASO](https://aibio.space/companies/vaso/) OTC: VASO - [INSULET CORP](https://aibio.space/companies/insulet/) NASDAQ: PODD - [MiniMed Group](https://aibio.space/companies/minimed/) NASDAQ: MMED - [BIO-TECHNE](https://aibio.space/companies/bio-techne/) NASDAQ: TECH - [Opthea](https://aibio.space/companies/opthea/) OTC: CKDXF ### Also on OTC - [CV Sciences](https://aibio.space/companies/cv-sciences/) CVSI - [Semnur Pharmaceuticals](https://aibio.space/companies/semnur-pharmaceuticals/) SMNR - [LUCY SCIENTIFIC DISCOVERY INC](https://aibio.space/companies/lucy-scientific-discovery/) LSDIF - [Earth Science Tech](https://aibio.space/companies/earth-science-tech/) ETST - [Ocean Biomediacal](https://aibio.space/companies/ocean-biomediacal/) OCEA - [CURATIVE BIOTECHNOLOGY INC.](https://aibio.space/companies/curative-biotechnology/) CUBT ## Adia Med annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$700,508](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | [$6,380](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | | Research and development | [$29,144](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | [$0](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | | Net income (loss) | [-$395,464](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | [-$181,067](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | | Cash from operations | [-$179,228](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | [-$335,476](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | | Cash and equivalents | [$79,392](https://www.sec.gov/Archives/edgar/data/1160420/000168316826006313/) | [$6,323](https://www.sec.gov/Archives/edgar/data/1160420/000168316826002531/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $128,115. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Adia Med What is the ticker symbol of Adia Med? Adia Med, Inc. trades under the ticker ADIA on OTC. Where is Adia Med listed? Adia Med, Inc. is listed on OTC. Which country or territory is Adia Med listed under? Our directory records Adia Med, Inc. under United States. Does aibio.space cover Adia Med? aibio.space lists Adia Med, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Adia Med's revenue last year? $700,508 for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Adia Med profitable? Adia Med, Inc. reported a net loss of $395,464 for the fiscal year ended Dec 31, 2025, and used $179,228 of cash in operations, per its annual report to the SEC. How much does Adia Med spend on research and development? $29,144 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Adia Med have? $128,115 in cash at Jun 30, 2026, per its 10-Q. What is the latest Adia Med (ADIA) stock news? Our latest story on Adia Med, dated Oct 6, 2026: "Adia Med agrees to sell 30% of Adia Labs to QCM Biologics for $1,500,000". The buyer, run by David Konn, pays $1,000,000 in cash and signs a $500,000 note at 7% interest, secured by a pledge of the units. [Source](https://aibio.space/news/adia-med-agrees-sell-30-percent-adia-labs-qcm-biologics-1-500-000/). Is Adia Med being acquired or merging? Our latest merger story, dated Oct 6, 2026: "Adia Med agrees to sell 30% of Adia Labs to QCM Biologics for $1,500,000". The buyer, run by David Konn, pays $1,000,000 in cash and signs a $500,000 note at 7% interest, secured by a pledge of the units. [Source](https://aibio.space/news/adia-med-agrees-sell-30-percent-adia-labs-qcm-biologics-1-500-000/). How can I follow Adia Med (ADIA) news? Press Follow on this page to add Adia Med to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Adia Med so far, in Mergers. ## Investor discussion: Adia Med Members talk about Adia Med (ADIA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Adia Med, newest first. Each line links the filing it comes from. 1. 2026-10-13 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1160420/000168316826007770/adia_8k.htm) 2. 2026-10-06 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1160420/000168316826007632/adia_8k.htm) 3. 2026-10-05 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1160420/000168316826007624/adia_ex9901.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:ADIA on TradingView](https://www.tradingview.com/symbols/OTC-ADIA/). ## Listing details Adia Med, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker ADIA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Adia Med, Inc. - **Ticker**: ADIA - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/adia-med/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Adia Med (ADIA) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/adia-med/